KRT5 and viral infectious disease: Consistently, KRT5-CreERT2 lineage labeled cells did not contribute to AT1 or AT2 cells no matter Tmx was administered before or after viral infection (data not shown), which is in line with previous studies (Kanegai et al., 2016; Vaughan et al., 2015).